Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telitacicept”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)Looking for participantsNCT05998759
What this trial is testing

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

Who this might be right for
Connective Tissue DiseasesThrombocytopenia
Beijing Hospital 296
Large-scale testing (Phase 3)WithdrawnNCT06456567
What this trial is testing

Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)

Who this might be right for
Systemic Lupus Erythematosus
Vor Biopharma
Not applicableUnknownNCT05644210
What this trial is testing

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Who this might be right for
Antiphospholipid Syndrome
Qilu Hospital of Shandong University 80
Early research (Phase 1)Study completedNCT05247203
What this trial is testing

Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
RemeGen Co., Ltd. 92
Not applicableLooking for participantsNCT06654596
What this trial is testing

Efficacy and Safety of Telitacicept in IgAN

Who this might be right for
IgA Nephropathy (IgAN)Kidney DiseasesTelitacicept+1 more
Ruijin Hospital 118
Not applicableActive Not RecruitingNCT07053137
What this trial is testing

A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

Who this might be right for
Systemic Lupus ErythematosusTelitaciceptBelimumab+1 more
Yipeng Liu 180
Post-approval studies (Phase 4)Looking for participantsNCT05962840
What this trial is testing

Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)

Who this might be right for
ANCA Associated Vasculitis
Chinese SLE Treatment And Research Group 40
Large-scale testing (Phase 3)Study completedNCT05737160
What this trial is testing

Study of Telitacicept in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
RemeGen Co., Ltd. 114
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614985
What this trial is testing

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Renmin Hospital of Wuhan University 172
Large-scale testing (Phase 3)Not Yet RecruitingNCT07052981
What this trial is testing

Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis

Who this might be right for
IgA Nephropathy (IgAN)IgAVN
Guixia Ding 124
Large-scale testing (Phase 3)Active Not RecruitingNCT07098897
What this trial is testing

To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
The Affiliated Hospital of Xuzhou Medical University 150
Not applicableUnknownNCT05588830
What this trial is testing

The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study

Who this might be right for
Lupus NephritisBelimumabTelitacicept
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Not applicableNot Yet RecruitingNCT06827587
What this trial is testing

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia GravisAutoimmune DiseasesNeuromuscular Diseases
First Affiliated Hospital of Wenzhou Medical University 60
Large-scale testing (Phase 3)Ended earlyNCT05306574
What this trial is testing

Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)

Who this might be right for
Systemic Lupus Erythematosus
Vor Biopharma 91
Large-scale testing (Phase 3)Not Yet RecruitingNCT07355257
What this trial is testing

TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)

Who this might be right for
Inflammatory Myopathy
Zhongming Qiu 30
Post-approval studies (Phase 4)UnknownNCT05666336
What this trial is testing

Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
Fen Li 30
Testing effectiveness (Phase 2)Looking for participantsNCT06375005
What this trial is testing

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, School of Medicine, Zhejiang University 38
Not applicableLooking for participantsNCT06394063
What this trial is testing

Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
RenJi Hospital 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT06656962
What this trial is testing

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

Who this might be right for
Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07008196
What this trial is testing

Telitacicept for the Treatment of Refractory RA

Who this might be right for
Rheumatoid Arthritis (RA)
Chinese SLE Treatment And Research Group 30
Load More Results